• Born October 1963
• Danish national 
• Member of the Board of Directors since 2017
• Vice Chairman of the Board of Directors since 2018
• Member of the Audit and Nomination Committee
• Independent board member

Present managerial positions

Mr. Brandgaard serves as President of the Novo Nordisk Haemophilia Foundation Council, Switzerland. Further, Mr. Brandgaard serves as Vice Chairman of the Board of William Demant Invest A/S, member of the Board of William Demant Fonden, and as a member of the Advisory Board of the private equity company, Vækst Partner Kapital, all in Denmark.

Board competencies

Experience from group management in a multinational pharmaceutical company, including responsibility for strategy development and implementation, information technology and finance. Financial and accounting experience.

Education

Mr. Brandgaard holds an MSc in Economics and Auditing, as well as an MBA, both from the Copenhagen Business School, Denmark.